These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36222710)

  • 1. Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
    Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt KA; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; ; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim BG; Kim JW; Kim JH; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park SY; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; ; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ
    Clin Cancer Res; 2022 Dec; 28(24):5383-5395. PubMed ID: 36222710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkers.
    Genestie C; Auguste A; Al Battal M; Scoazec JY; Gouy S; Lacroix L; Morice P; Pautier P; Leary A; Devouassoux-Shisheboran M
    Virchows Arch; 2021 May; 478(5):885-891. PubMed ID: 33009577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltrative pattern of invasion is independently associated with shorter survival and desmoplastic stroma markers FAP and THBS2 in mucinous ovarian carcinoma.
    Köbel M; Kang EY; Lee S; Terzic T; Karnezis AN; Ghatage P; Woo L; Lee CH; Meagher NS; Ramus SJ; Gorringe KL
    Histopathology; 2024 Jun; 84(7):1095-1110. PubMed ID: 38155475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?
    Algera MD; van Driel WJ; van de Vijver KK; Kruitwagen RFPM; Lok CAR
    Curr Opin Oncol; 2022 Sep; 34(5):497-503. PubMed ID: 35838205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic and stromal expression of laminin γ 2 chain correlates with infiltrative invasion in ovarian mucinous neoplasms of gastro-intestinal type.
    Okuma E; Ohishi Y; Oda Y; Aishima S; Kurihara S; Nishimura I; Yasunaga M; Kobayashi H; Wake N; Tsuneyoshi M
    Oncol Rep; 2010 Dec; 24(6):1569-76. PubMed ID: 21042753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature.
    Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Tsuda H; Takano M
    J Ovarian Res; 2021 Feb; 14(1):33. PubMed ID: 33583413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of stage III mucinous and serous ovarian cancer: a case-control study.
    Firat Cuylan Z; Karabuk E; Oz M; Turan AT; Meydanli MM; Taskin S; Sari ME; Sahin H; Ulukent SC; Akbayir O; Gungorduk K; Gungor T; Kose MF; Ayhan A
    J Ovarian Res; 2018 Oct; 11(1):91. PubMed ID: 30376858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis.
    Hada T; Miyamoto M; Ishibashi H; Matsuura H; Kakimoto S; Iwahashi H; Tsuda H; Takano M
    Diagn Pathol; 2022 Jan; 17(1):12. PubMed ID: 35057833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving population-based statistics for rare epithelial ovarian cancers.
    Matsuo K; Machida H; Matsuzaki S; Grubbs BH; Klar M; Roman LD; Sood AK; Gershenson DM; Wright JD
    Gynecol Oncol; 2020 Apr; 157(1):3-11. PubMed ID: 31954534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors.
    Smithgall MC; Yemelyanova A; Mathew S; Gogineni S; He B; Zhang T; Robinson BD; Tu JJ
    Int J Gynecol Pathol; 2024 Mar; 43(2):134-139. PubMed ID: 37406458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study of characteristics and hyperthermia intraperitoneal perfusion in mucinous borderline ovarian tumor and mucinous ovarian carcinoma.
    He X; Ying R; Jia L; Li Y; Li R
    Gland Surg; 2023 Apr; 12(4):453-464. PubMed ID: 37200926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
    Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C
    Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis for mucinous ovarian carcinoma with infiltrative and expansile invasion and mucinous borderline tumor: a retrospective analysis.
    Hada T; Miyamoto M; Ohtsuka Y; Suminokura J; Ito T; Kishimoto N; Nishitani S; Takada M; Imauji A; Tanabe R; Takano M
    Diagn Pathol; 2023 Apr; 18(1):49. PubMed ID: 37081552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
    Rodríguez IM; Prat J
    Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L1-CAM in Mucinous Ovarian Carcinomas and Borderline Tumors: Impact on Tumor Recurrence and Potential Role in Tumor Progression.
    Wiedenhoefer R; Schmoeckel E; Grube M; Sulyok M; Pasternak I; Beschorner C; Greif K; Brucker S; Mayr D; Kommoss S; Fend F; Staebler A; Fischer AK
    Am J Surg Pathol; 2023 May; 47(5):558-567. PubMed ID: 36852510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases: A Population-Based Cancer Registry Study.
    Simons M; Ezendam N; Bulten J; Nagtegaal I; Massuger L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1208-15. PubMed ID: 25978291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular origin and taxonomy of mucinous ovarian carcinoma.
    Cheasley D; Wakefield MJ; Ryland GL; Allan PE; Alsop K; Amarasinghe KC; Ananda S; Anglesio MS; Au-Yeung G; Böhm M; Bowtell DDL; Brand A; Chenevix-Trench G; Christie M; Chiew YE; Churchman M; DeFazio A; Demeo R; Dudley R; Fairweather N; Fedele CG; Fereday S; Fox SB; Gilks CB; Gourley C; Hacker NF; Hadley AM; Hendley J; Ho GY; Hughes S; Hunstman DG; Hunter SM; Jobling TW; Kalli KR; Kaufmann SH; Kennedy CJ; Köbel M; Le Page C; Li J; Lupat R; McNally OM; McAlpine JN; Mes-Masson AM; Mileshkin L; Provencher DM; Pyman J; Rahimi K; Rowley SM; Salazar C; Samimi G; Saunders H; Semple T; Sharma R; Sharpe AJ; Stephens AN; Thio N; Torres MC; Traficante N; Xing Z; Zethoven M; Antill YC; Scott CL; Campbell IG; Gorringe KL
    Nat Commun; 2019 Sep; 10(1):3935. PubMed ID: 31477716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathological characteristics and survival outcomes of primary expansile
    Nistor S; El-Tawab S; Wong F; Zouridis A; Roux R; Manek S; Gaitskell K; Ahmed AA; Kehoe S; Soleymani Majd H
    Transl Cancer Res; 2023 Oct; 12(10):2682-2692. PubMed ID: 37969399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequency and prognostic role of P53 and P16 immunoexpression in primary ovarian mucinous tumors.
    Nergiz D; Yıldırım HT; Süren D; Sadullahoğlu C; Yıldırım Ş; Üreyen I
    Ann Diagn Pathol; 2024 Oct; 72():152330. PubMed ID: 38772285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation and Prognosis of Primary Expansile and Infiltrative Mucinous Carcinomas of the Ovary.
    Huin M; Lorenzini J; Arbion F; Carcopino X; Touboul C; Dabi Y; Kerbage Y; Costaz H; Lecointre L; Lavoué V; Bolze PA; Huchon C; Bricou A; Canlorbe G; Mimoun C; Bendifallah S; Gauthier T; Body G; Ouldamer L;
    J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.